Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

The session will provide an introduction to benefit-risk assessment, with a focus on formal postmarketing risk management, primarily in the US and EU context. This session will encompass postmarketing risk assessment, Risk Management Plans (RMPs), and Risk Evaluation and Mitigation Strategies (REMS).